Paediatric Research Society children and in children with renal disease. More accurate measurement was possible, particularly if a 4-hour specimen was used rather than an overnight 12-hour specimen. However, there are so many variable errors in any method of estimating cell excretion rates, that the method could well be discarded in paediatric practice.
Cell concentration in a random urine specimen is easily estimated, a fresh mid-stream sample being examined in a counting chamber. This test combined with the Hemastix test for blood gives sufficient information for the management of children with renal disease.
Auto-immune Disease in the NZB/Bi Mice Ron Barnes London Since the original description of the inbred NZB/B1 strain of mice by Bielschowsky, Helyer, and Howie (1959) , a considerable amount of data have accumulated concerning the auto-immune disease that characterizes this mouse. We, as others, have investigated a possible genetic basis for the disease by hybridization. The results of this study suggest that if there is any genetic mechanism it must necessarily be very complex to account for all the findings in the NZB x CFW hybrid. An alternative environmental aetiological agent seems more likely. One method of investigating such an agent is the introduction and examination of the NZB/B1 in different environments. The fact that the NZB/B1 still develop their characteristic disease in both the 'specific pathogen free' and 'germ-free' states does not necessarily exclude an infective aetiology In both situations transplacental passage during the initial introduction of the animals is still possible, and perhaps confirmed by the electron microscopical demonstration of virus-like particles in 'germ-free' NZB/B1. To investigate the transplacental passage of the proposed infective agent, ovum transplantation was successfully performed, and preliminary data were presented upon the effect of nurturing fertilized normal mouse ova to term in the uterus of the auto-immune NZB/B1. In the presence of pulmonary disease THAM has a theoretical superiority over sodium bicarbonate in that it not only combines directly with CO2 in the plasma and promotes its excretion in the urine, but generates bicarbonate ion in the process, without adding sodium ions to the circulation. Adults with a hypercapnic acidosis are, however, known to suffer respiratory depression or even apnoea after its administration.
The use of THAM in newborn babies suffering from respiratory distress has been reviewed over a three-year period. 74 babies who were breathing spontaneously received a dose of the drug, and 15 of these had an episode of marked respiratory depression or apnoea in the two minutes after the injection; 2 of the 15 had cardiac arrests. No apnoea has been seen after sodium bicarbonate administration.
THAM solutions of two strengths (3-6%' and 7%) were used. The 7% solution was, in general, used in the sickest, most acidotic babies, and it was noticed that there was a significantly higher incidence of intraventricular haemorrhage in those babies who received 7%THAM.
It has been suggested that early administration of THAM may effect a permanent improvement in the pulmonary hypoperfusion in the respiratory distress syndrome, but similar improvement has been noted in babies receiving sodium bicarbonate.
The theoretical advantages of using THAM must be weighed against the danger of causing apnoea.
